Compare EBMT & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EBMT | ACB |
|---|---|---|
| Founded | 1922 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.5M | 164.8M |
| IPO Year | 2009 | 2016 |
| Metric | EBMT | ACB |
|---|---|---|
| Price | $23.47 | $2.77 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $24.00 | N/A |
| AVG Volume (30 Days) | 40.4K | ★ 1.2M |
| Earning Date | 04-28-2026 | 06-17-2026 |
| Dividend Yield | ★ 2.55% | N/A |
| EPS Growth | ★ 53.23 | N/A |
| EPS | ★ 0.51 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.31 |
| Revenue Next Year | $5.00 | N/A |
| P/E Ratio | $46.35 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.50 | $2.56 |
| 52 Week High | $24.66 | $6.67 |
| Indicator | EBMT | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 54.63 | 49.30 |
| Support Level | $22.68 | $2.73 |
| Resistance Level | $24.12 | $2.98 |
| Average True Range (ATR) | 0.76 | 0.08 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 62.50 | 79.63 |
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.